Skip to main content
. Author manuscript; available in PMC: 2024 Feb 5.
Published in final edited form as: Vaccine. 2010 Dec 31;29(39):6763–6770. doi: 10.1016/j.vaccine.2010.12.055

Figure 4. Antibody Titers.

Figure 4.

Sera were tested for antibodies capable of binding to HIV-1 envelope gp120, CN54, derived from a subject infected with clade C. Antibody titers are presented for (A) after the final immunization, prior to challenge and (B) post challenge.